Abstract
Managing patients with a history of intravenous bisphosphonates and antiresorptive medications poses challenges in clinical decision-making. Extractions are generally discouraged in these patients due to the risk of medication-related osteonecrosis of the jaw (MRONJ). This case study presents an 89-year-old female with metastatic breast cancer on Xgeva, facing a non-restorable tooth (#30). A collaborative approach involving the general dentist, endodontist, and oral surgeon employed endodontic therapy, crown amputation, and soft tissue advancement, avoiding extraction. The technique, akin to coronectomy, mitigates MRONJ risk by preserving bone integrity. Follow-up assessments indicate successful treatment without complications, highlighting the efficacy of this approach in managing challenging cases.
Recommended Citation
Daws, Timothy DDS and Bolten, Thomas DDS, MD
(2023)
"Endodontic Therapy, Crown Amputation, and Soft Tissue Advancement to Treat a Hopeless Tooth,"
The Journal of the Michigan Dental Association: Vol. 105:
No.
12, Article 6.
Available at:
https://commons.ada.org/journalmichigandentalassociation/vol105/iss12/6
Included in
Dental Public Health and Education Commons, Endodontics and Endodontology Commons, Health Law and Policy Commons, Human Resources Management Commons, Leadership Commons, Oral and Maxillofacial Surgery Commons
Submit Article
